Industries > Pharma > Global Defibrillators Market Forecast 2019-2029

Global Defibrillators Market Forecast 2019-2029

External Defibrillators, Implantable Cardioverter Defibrillators, Transvenous ICD, Subcutaneous ICD, Single-Chamber ICD, Dual-Chamber ICD, Cardiac Resynchronization Therapy Defibrillators (CRT-D), Manual External Defibrillators, Automated External Defibrillators, Wearable Cardioverter Defibrillators

PUBLISHED: 19 December 2018
PAGES: 179
PRODUCT CODE: PHA0348
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0348 Categories: , Tags: ,

The global defibrillators market is expected to grow at a CAGR of 5.2% from 2017-2022. The market is expected to grow at a CAGR of 6.1% from 2017 to 2029. In 2018, the Implantable Cardioverter Defibrillators segment held 77% of the global defibrillators market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand-new report, you find 179-page report you will receive 74 tables and 125 figures – all unavailable elsewhere.

The 179-page report provides clear detailed insight into the global defibrillators market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Global Defibrillators Market forecast 2019-2029

• Global Defibrillators market forecast by product:

• Implantable Cardioverter Defibrillators (ICDs)
• Transvenous ICDs (T-ICDs)
– Single-Chamber ICDs
– Dual-Chamber ICDs
– Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)

• Subcutaneous ICDs (S-ICDs)

• External Defibrillators
• Manual External Defibrillators

• Automated External Defibrillators (AEDs)
– Semi-Automated External Defibrillators
– Fully-Automated External Defibrillators

• Wearable Cardioverter Defibrillators (WCDs)

• Global Defibrillators market forecast by end-user:
• Hospitals and Cardiac Centers
• Pre-hospital Services
• Public Access
• Home Care
• Other-End User

• Global Defibrillators National Market forecast 2019-2029, covering:

• North America
• US
• Canada

• Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

• Asia-Pacific:
• Japan
• China
• India
• Rest of Asia-Pacific

• Rest of the World
• Latin America
• Middle East
• Africa

Global Defibrillators Market Forecast 2019-2029

• Analysis of the key factors driving and restraining the growth of the defibrillators market

• Assessment of selected leading companies, examining recent performance and outlooks:
• Abbott Laboratories
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardiac Science Corporation
• LivaNova PLC
• Medtronic PLC
• Nihon Kohden Corporation
• Phillips Healthcare
• Physio Control Inc.
• Zoll Medical Corporation

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Defibrillators Market and leading companies. You find data, trends and predictions.

Buy our report today Global Defibrillators Market Forecast 2019-2029: External Defibrillators, Implantable Cardioverter Defibrillators, Transvenous ICD, Subcutaneous ICD, Single-Chamber ICD, Dual-Chamber ICD, Cardiac Resynchronization Therapy Defibrillators (CRT-D), Manual External Defibrillators, Automated External Defibrillators, Wearable Cardioverter Defibrillators.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Defibrillators Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Defibrillators Market Forecast 2019-2029


Latest Pharma news

“Global Influenza Vaccines Market Set to Grow to $4.9bn by 2024” says new Visiongain report

The global vaccines market is one that is driven by innovation. This is vital for maintaining the rich pipeline of vaccines seen in the human vaccines market.

05 July 2019

READ

“Pharmaceutical Wholesale & Distribution Organizations 2019 is estimated to reach $1.4bn in 2024” says Visiongain report

Opportunities in the market stem from the increasing use of specialist and generic drugs, which have higher profit margins; global expansion into the emerging markets; vertical integration of wholesalers; and the increasing use of pharmaceuticals.

28 June 2019

READ

“Global Vaccines Sales market set to grow to $75bn by 2024” says new Visiongain report

Progress in R&D in the therapeutic vaccine field will yield revolutionary results and answer unmet medical needs. This will also lead to more innovative approaches to vaccine development.

25 June 2019

READ

“Global Inflammatory Bowel Diseases (IBD) Drug Market is estimated to reach $8.6bn by 2024” says new Visiongain report

Revenue growth will be driven by rising incidence and prevalence owing to modern lifestyles and improved awareness and diagnosis.

21 June 2019

READ

Categories

Category